Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'
Go back to Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.24 -0.14 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.38 | 52 Week High | $42.49 | |||
| Open | $28.26 | 52 Week Low | $16.64 | |||
| Day High | $28.43 | P/E | N/A | |||
| Day Low | $27.90 | EPS | $-0.42 | |||
| Volume | 1,062,579 | |||||
| (NASDAQ: SLNO) | Delayed: 53.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.01 | 52 Week High | $ | |||
| Open | $53.01 | 52 Week Low | $ | |||
| Day High | $53.01 | P/E | N/A | |||
| Day Low | $53.01 | EPS | $ | |||
| Volume | 122,645 | |||||

